[1]
Wetwittayakhlang, P., Golovics, P., Khoury, A., Ganni, E., Hahn, G., Cohen, A., Wyse, J., Bradette, M., Bessissow, T., Afif, W., Wild, G., Bitton, A. and Lakatos, P. 2022. Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study. Journal of Gastrointestinal and Liver Diseases. 31, 4 (Dec. 2022), 403-410. DOI:https://doi.org/10.15403/jgld-4375.